XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Awards (Tables)
9 Months Ended
Sep. 30, 2023
Stock-Based Awards  
Assumptions used to determine fair value of stock options granted

    

Nine Months Ended

September 30, 

2023

2022

 

Risk-free interest rate

 

3.53

%

2.07

%

Expected term (in years)

 

6.2

6.2

Expected volatility

 

77.73

%

77.95

%

Expected dividend yield

 

0

%

0

%

Summary of stock option activity

    

    

    

Weighted

    

Weighted

Average

Average

Remaining

Aggregate

Number

Exercise

Contractual

Intrinsic

(In thousands, except share and per share data and years)

of Shares

Price

Term

Value

(in years)

Outstanding as of December 31, 2022

 

5,167,164

$

16.04

 

7.2

$

15,288

Granted

 

2,218,550

15.71

Exercised

(34,269)

1.30

$

319

Forfeited and cancelled

 

(228,990)

15.71

Outstanding as of September 30, 2023

 

7,122,455

$

16.02

 

7.1

$

3,680

Options vested and expected to vest as of September 30, 2023

 

7,122,455

$

16.02

 

7.1

$

3,680

Options exercisable as of September 30, 2023

 

3,190,762

$

16.70

 

4.7

$

3,323

Summary of restricted stock units activity

Weighted

Average

Grant Date

Aggregate

Number

Fair Value

Intrinsic

(In thousands, except share and per share data)

of Shares

Per Share

Value

Outstanding as of December 31, 2022

1,520,730

$

14.02

Granted

980,700

15.32

Vested

(706,167)

11.61

$

8,141

Forfeited and cancelled

(88,073)

15.68

Outstanding as of September 30, 2023

1,707,190

$

15.68

Stock-based compensation expense

Three Months Ended

Nine Months Ended

 

September 30, 

September 30, 

 

(In thousands)

    

2023

    

2022

    

2023

    

2022

 

Cost of revenue

    

$

347

    

$

307

  

$

1,119

    

$

837

Research and development

3,072

1,400

9,168

2,228

General and administrative

 

2,529

 

2,481

 

8,989

 

7,161

Total stock-based compensation expense

$

5,948

$

4,188

$

19,276

$

10,226